Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dental plaque is a biofilm composed of bacteria that adhere to the tooth surface, embedded in a matrix of extracellular polymeric substances. Bacterial enzymes, such as glucansucrase, levan sucrase, levan hydrolase, polysaccharide hydrolases (mutanases and dextranases), proteases, and FruA, play critical roles in the formation, maintenance, and degradation of this biofilm. These enzymes enable initial colonization by converting dietary sugars into adhesive polymers, maintain structural integrity, and contribute to pathogenicity through acid production. Targeting these enzymes offers therapeutic strategies for caries prevention, including inhibitors against glucansucrase or enzyme-based therapies to degrade plaques.
Enzyme inhibition; Substrate competition; Biofilm disruption
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dental Plaque Bacterial Enzymes.